SHAPING THE FUTURE OF EUROPEAN HEALTH TECHNOLOGY ASSESSMENTS: EXPERIENCES OF THREE PHARMACEUTICAL JOINT RAPID RELATIVE EFFECTIVENESS ASSESSMENTS

被引：0
|
作者：
Willemsen, A. [1 ]
Estevao, S. [1 ]
Dupree, R. [1 ]
机构：
[1] Zorginst Nederland, Diemen, Netherlands
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1185
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP291
引用
收藏
页码：S199 / S200
页数：3
相关论文
共 50 条
  • [21] Access to Innovative Neurological Drugs in Europe: Alignment of Health Technology Assessments Among Three European Countries
    Gozzo, Lucia
    Romano, Giovanni Luca
    Brancati, Serena
    Cicciu, Marco
    Fiorillo, Luca
    Longo, Laura
    Vitale, Daniela Cristina
    Drago, Filippo
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [22] VALUE OF DATABASES OTHER THAN MEDLINE FOR RAPID HEALTH TECHNOLOGY ASSESSMENTS
    Lorenzetti, Diane L.
    Topfer, Leigh-Ann
    Dennett, Liz
    Clement, Fiona
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (02) : 173 - 178
  • [23] COLLABORATIVE MODELS FOR THE JOINT PRODUCTION OF CORE HEALTH TECHNOLOGY ASSESSMENTS: NEGATIVE AND POSITIVE ASPECTS FOR THE JOINT WORK OF DIFFERENT EUROPEAN AGENCIES
    Lo Scalzo, Alessandra
    Vicari, Nicola
    Corio, Mirella
    Perrini, Maria Rosaria
    Jefferson, Tom
    Gillespie, Francesca
    Cerbo, Marina
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (05) : 536 - 543
  • [24] IS IT JUST SEMANTICS? THE USE OF "EFFICACY" AND "EFFECTIVENESS" IN COMPARATIVE EFFECTIVENESS REVIEWS AND HEALTH TECHNOLOGY ASSESSMENTS
    Jaksa, A.
    Rubinstein, E.
    Ho, Y. S.
    Daniel, K.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A488 - A488
  • [25] Endpoints for safety in health technology assessments-The experiences of the Danish Medicines Council
    Rasmussen, Anna Roe
    Christensen, Hanne Rolighed
    Jimenez-Solem, Espen
    [J]. HEALTH POLICY AND TECHNOLOGY, 2022, 11 (04)
  • [26] TRENDS IN HEALTH TECHNOLOGY ASSESSMENTS SINCE THE INTRODUCTION OF COST-EFFECTIVENESS IN THE NETHERLANDS
    Dvortsin, E.
    Vondeling, G.
    van der Woude, T.
    Postma, M. J.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A833 - A833
  • [27] Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysis
    Postma, Maarten J.
    Boersma, Cornelis
    Vandijck, Dominique
    Vegter, Stefan
    Le, Hoa H.
    Annemans, Lieven
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (04) : 367 - 369
  • [28] Transporting Comparative Effectiveness Evidence Between Countries: Considerations for Health Technology Assessments
    Alex J. Turner
    Cormac Sammon
    Nick Latimer
    Blythe Adamson
    Brennan Beal
    Vivek Subbiah
    Keith R. Abrams
    Joshua Ray
    [J]. PharmacoEconomics, 2024, 42 : 165 - 176
  • [29] Subgroup analyses in cost-effectiveness analyses to support health technology assessments
    Fletcher, Christine
    Chuang-Stein, Christy
    Paget, Marie-Ange
    Reid, Carol
    Hawkins, Neil
    [J]. PHARMACEUTICAL STATISTICS, 2014, 13 (04) : 265 - 274
  • [30] Transporting Comparative Effectiveness Evidence Between Countries: Considerations for Health Technology Assessments
    Turner, Alex J.
    Sammon, Cormac
    Latimer, Nick
    Adamson, Blythe
    Beal, Brennan
    Subbiah, Vivek
    Abrams, Keith R.
    Ray, Joshua
    [J]. PHARMACOECONOMICS, 2024, 42 (02) : 165 - 176
12345